19-02-2009: Biotage announced that the company will enter the peptide synthesis business, through two new agreements with German company MultiSynTech GmbH. The agreements concern both the distribution rights for MultiSynTech's systems and the establishment of a joint development project.
The agreements with MultiSynTech will grant Biotage distribution rights for all current MultiSynTech peptide synthesis systems. Biotage and MultiSynTech have also agreed on a joint development project to design and market a new microwave-aided peptide synthesis system, which will increase yield and speed in peptide synthesis.
"We look forward to working in close collaboration with Biotage. Biotage has a proven sales and support team that dramatically expands our coverage outside Central Europe, and really opens opportunities for our current products in USA, UK, Nordic and Asian regions." says Udo Treffer, CEO of MultiSynTech.
"MultiSynTech is the clear leader in robotic peptide synthesis. This joint development project will combine the proven performance of the current MultiSynTech robotic synthesizer with Biotage microwave technology in a unique integrated system." says Torben Jørgensen, CEO of Biotage.
Biotage announced a collaborative research agreement with The Laboratory of Peptide & Protein Chemistry & Biology (PeptLab) located in Florence, Italy. The peptide research facility, led by Professor Anna Maria Papini, has agreed to contribute technical input towards the future development ... more
Biotage announced an agreement to extend the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The collaboration builds ... more
Biotage AB announced that the parties have signed a definitive agreement under which Biotage will acquire all outstanding shares in MIP Technologies, a privately held leading developer of molecularly imprinted polymers (MIPs) and other novel polymers.
MIP Technologies is a company working ... more
Biotage announced that the company will enter the peptide synthesis business, through two new agreements with German company MultiSynTech GmbH. The agreements concern both the distribution rights for MultiSynTech's systems and the establishment of a joint development project.
The agreement ... more
The MultiSynTech Company develops accessories for peptide and combinatorial chemistry, as well as for automated synthesis. Our synthesis machines are used for parallel synthesis in solid phases as well as for solution chemistry. more